Skip to main content
Unknown status

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

By April 24, 2017No Comments

Condition

Malignant Mesothelioma|Metastatic Cancer

Estimated Enrollment: 270

Age Group: Child, Adult, Senior

Gender: All

Study Type: Observational

Study Design Allocation:

Study ID Numbers: CDR0000564050|INCA-RECF0433|INCA-05-145|INCA-Mesothel

Study First Received: May 9, 2009

Last Updated: December 13, 2009

Estimated Primary Completion Date: January 2010

 

Primary Outcome Measures:

Mesothelin and osteopontin concentrations in serum|Cytological, histological, immunohistochemical, and molecular markers of precancerous disease in tissue samples|Role of SV40|Relationship of serum concentration of mesothelin and/or osteopontin with the expression of other markers and with clinical progression

Sponsors and Collaborators:

University Hospital, Caen|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00899613

Leave a Reply